# Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer

> **NCT06938724** · PHASE2 · RECRUITING · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 152 (estimated)

## Conditions studied

- Breast Neoplasm Malignant Female

## Interventions

- **OTHER:** Omission of local therapies

## Key facts

- **NCT ID:** NCT06938724
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-25
- **Primary completion:** 2035-07-25
- **Final completion:** 2035-07-25
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938724, "Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06938724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*